How do I prepare a glucagon infusion (reconstitute and dilute) for continuous administration in severe hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Glucagon Infusion Preparation

For continuous glucagon infusion in severe hypoglycemia, reconstitute the 1 mg glucagon powder with the supplied diluent to create a 1 mg/mL solution, then dilute this to the desired concentration (typically 1 mg in 100-250 mL of D5W or normal saline) for IV administration under medical supervision only. 1

Reconstitution Process

  • Insert the entire contents of the prefilled syringe (diluent) through the rubber stopper into the vial containing glucagon powder 1
  • Swirl gently (do not shake vigorously) until the powder is completely dissolved and no particles remain 1
  • The reconstituted solution should be clear and water-like in consistency—if cloudy or containing particulate matter, discard and do not use 1
  • The reconstituted concentration is 1 mg/mL glucagon 1

Dilution for Continuous Infusion

While the FDA label primarily addresses bolus dosing, continuous infusions in hospital settings typically follow these principles:

  • Use the reconstituted 1 mg/mL solution immediately after preparation 1
  • For continuous IV infusion, dilute in compatible IV fluids (D5W or normal saline) to achieve desired infusion rate 2
  • Standard dilution protocols in critical care often use 1 mg glucagon in 100-250 mL of IV fluid, though this must be determined by the treating physician based on clinical needs

Critical Administration Points

  • Glucagon for continuous IV infusion must ONLY be administered under direct medical supervision in a monitored setting 1
  • Use immediately after reconstitution—glucagon is biochemically unstable in liquid form and any unused portion must be discarded 1, 3
  • Traditional glucagon powder formulations have major stability limitations, which is why newer ready-to-use preparations (intranasal, prefilled pens) are now preferred for emergency use 4, 3

Post-Administration Management

  • Once the patient responds and can safely swallow, immediately provide oral carbohydrates to restore liver glycogen and prevent recurrence of hypoglycemia 5, 1
  • Monitor blood glucose closely as the effects of glucagon are temporary and hypoglycemia may recur 4

Important Caveats

Continuous glucagon infusion is rarely used in modern practice—it is primarily reserved for specific scenarios like refractory hypoglycemia from sulfonylurea overdose or insulinoma management in hospitalized patients. For severe hypoglycemia treatment, IV dextrose (20-40 mL of 50% glucose solution) is the preferred initial therapy in medical settings 5, with glucagon reserved for situations where IV access is unavailable or as adjunctive therapy.

The complexity of reconstitution and instability of traditional glucagon preparations is precisely why newer formulations (intranasal glucagon, dasiglucagon, ready-to-inject preparations) have been developed and are now strongly preferred for emergency hypoglycemia treatment 4, 6.

Related Questions

Can I administer glucagon (Glucagon) intramuscularly (IM) for severe hypoglycemia?
Is sublingual lubrication of wetted table sugar effective in treating hypoglycemia in a confused patient when intravenous (IV) glucose or intramuscular (IM) glucagon is not available?
Should glucagon be used in patients on any antidiabetic medication who are at risk for hypoglycemia?
What is the recommended glucagon dosing order for an adult with severe hypoglycemia (blood glucose ≤50 mg/dL or neuroglycopenic symptoms), including weight‑based adjustments and repeat dosing?
Can glucagon be safely reconstituted with normal saline instead of sterile water?
What is the recommended dosing and administration schedule for aztreonam combined with ceftazidime‑avibactam in adults (including renal function adjustments) and in pediatric patients ≥3 months?
For an adult with mild‑to‑moderate hallux valgus, which of these modalities—ultrasound therapy, short‑wave diathermy, transcutaneous electrical nerve stimulation (TENS), manipulation, multiple exercises, manual and skin traction—are supported by current clinical‑practice guidelines?
What is Fanconi syndrome, including its causes, clinical presentation, diagnostic work‑up, and management?
What is the optimal sleep pattern and sleep‑hygiene recommendations for an elderly adult (≥65 years)?
What diagnostic criteria for Specific Phobia have changed across DSM‑III, DSM‑III‑TR, DSM‑IV, DSM‑5, DSM‑5‑TR, ICD‑10, and ICD‑11?
In a 36‑week gravida with persistent vaginal bleeding and a breech fetus, when should external cephalic version be performed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.